Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
2.010
+0.140 (7.49%)
Oct 20, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Employees
Foghorn Therapeutics had 106 employees as of December 31, 2025. The number of employees decreased by 6 or -5.36% compared to the previous year. That makes Foghorn Therapeutics the 31,051st largest employer in the world and 3,966th in the United States.
Employees
106
Change (1Y)
-6
Growth (1Y)
-5.36%
Revenue / Employee
$346,594
Profits / Employee
-$609,236
Market Cap
119.36M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -6 | -5.36% |
| Dec 31, 2024 | 112 | -4 | -3.45% |
| Dec 31, 2023 | 116 | -45 | -27.95% |
| Dec 31, 2022 | 161 | 42 | 35.29% |
| Dec 31, 2021 | 119 | 24 | 25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Nkarta | 106 |
| Armata Pharmaceuticals | 61 |
| Anavex Life Sciences | 34 |
| Cue Biopharma | 29 |
| Spruce Biosciences | 22 |
| TuHURA Biosciences | 22 |
| Black Diamond Therapeutics | 21 |
FHTX News
- 7 days ago - Foghorn Therapeutics downgraded to In Line from Outperform at Evercore ISI - TheFly
- 9 days ago - FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law - Business Wire
- 18 days ago - Wedbush downgrades Foghorn on end of Lilly collaboration - TheFly
- 18 days ago - Foghorn Therapeutics downgraded to Neutral from Outperform at Wedbush - TheFly
- 18 days ago - Foghorn Therapeutics price target lowered to $5 from $12 at Guggenheim - TheFly
- 18 days ago - Foghorn Therapeutics price target lowered to $5 from $13 at H.C. Wainwright - TheFly
- 19 days ago - Foghorn Therapeutics downgraded to Hold from Buy at TD Cowen - TheFly
- 19 days ago - Foghorn Therapeutics downgraded to Neutral from Buy at BTIG - TheFly